Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the Treatment of Symptomatic Subacute and Chronic Subdural Hematoma Via Middle Meningeal Artery Embolization With the NeoCastTM Embolic System (RADIANT)

NCT07541404 is registered in ClinicalTrials.gov with Arsenal Medical, Inc. as lead sponsor.

NCT NCT07541404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07541404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the Treatment of Symptomatic Subacute and Chronic Subdural Hematoma Via Middle Meningeal Artery Embolization With the NeoCastTM Embolic System (RADIANT)
Lead sponsor
Arsenal Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 13, 2026
Completion date
April 30, 2028
Enrollment
360 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma